NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TGTX) today announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback